APA (7th ed.) Citation

Baker, P., Zubrzycka-Sienkiewicz, A., Klama, K., Ullmann, M., Petit-Frere, C., Monnet, J., & Illes, A. Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: Results of a randomised double-blind study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Baker, Peter, Anna Zubrzycka-Sienkiewicz, Kamilla Klama, Martin Ullmann, Corinne Petit-Frere, Joëlle Monnet, and Andras Illes. Comparison of the Efficacy and Safety of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Subjects with Moderate-to-severe Rheumatoid Arthritis: Results of a Randomised Double-blind Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Baker, Peter, et al. Comparison of the Efficacy and Safety of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Subjects with Moderate-to-severe Rheumatoid Arthritis: Results of a Randomised Double-blind Study. BMJ Publishing Group.